Risk factors associated with a low glomerular filtration rate in primary aldosteronism

J Clin Endocrinol Metab. 2009 Mar;94(3):869-75. doi: 10.1210/jc.2008-1851. Epub 2008 Dec 30.

Abstract

Context: Primary aldosteronism (PA) is associated with vascular end organ damage.

Objective: We evaluated the newly established German Conn's Registry for evidence of renal impairment and compared the data with those from hypertensive subjects of a population-based survey.

Design: We conducted a case-control study.

Patients and controls: A total of 408 patients with PA from the Conn's registry treated in five German centers were matched for age, sex, and body mass index in a 1:1 ratio with 408 hypertensive control subjects from the population-based F3 survey of the Kooperative Gesundheitsforschung in the region of Augsburg (KORA).

Main outcome measures: We measured serum creatinine and calculated glomerular filtration rate (GFR).

Results: The percentage of patients with a serum creatinine concentration above the normal range of 1.25 mg/dl was higher in patients with PA than in hypertensive controls (29 vs. 10%; P < 0.001). Regression analysis showed that age, male sex, low potassium, and high aldosterone concentrations were independent predictors of a lower GFR. Adrenalectomy reduced systolic blood pressure from a mean of 160 to 144 mm Hg. In parallel, we observed an increase in serum creatinine and a decrease of GFR from 71 to 64 ml/min (P < 0.001). A similar trend was seen after spironolactone treatment.

Conclusions: In a large cohort of patients with PA, markers of disease activity such as plasma aldosterone and serum potassium are independent predictors of a lower GFR. Specific interventions, such as adrenalectomy or spironolactone treatment, are associated with a further decline in GFR.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenalectomy
  • Adult
  • Aged
  • Case-Control Studies
  • Creatinine / blood
  • Female
  • Glomerular Filtration Rate*
  • Humans
  • Hyperaldosteronism / physiopathology*
  • Male
  • Middle Aged
  • Mineralocorticoids / antagonists & inhibitors
  • Risk Factors

Substances

  • Mineralocorticoids
  • Creatinine